Viridian Therapeutics, Inc.\DE (VRDN) Total Non-Current Liabilities (2014 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) reported Total Non-Current Liabilities of $421.45 million for Q2 2026, up 547.6% from $65.08 million a year earlier and up 199.9% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, Viridian Therapeutics, Inc.\DE posted Total Non-Current Liabilities of $157.22 million, up 129.7% from FY2024.
- Total Non-Current Liabilities has increased for five consecutive years, with a five-year compound annual growth rate of 69.7% (FY2020 to FY2025).
- By year, Total Non-Current Liabilities came in at $68.46 million in FY2024 (+44.4%), $47.41 million in FY2023 (+22.0%), $38.86 million in FY2022 (+162.8%) and $14.79 million in FY2021 (+32.3%).
- The Q2 2026 figure ranks as the highest quarterly Total Non-Current Liabilities in data going back to Q4 2014.
- Year over year, Total Non-Current Liabilities has now increased in each of the last 17 quarters, with growth averaging 121.4% over the last eight quarters.
- The high point for year-over-year Total Non-Current Liabilities in five years was Q2 2026 (growth of 547.6%); the low point was Q1 2022 (a decline of 8.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $140.51 million (Q1 2026), $157.22 million (Q4 2025) and $71.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.33 Bn | 2.33 Bn | - | 421.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 421.45 Mn |
| Mar 31, 2026 | 140.51 Mn |
| Dec 31, 2025 | 157.22 Mn |
| Sep 30, 2025 | 71.59 Mn |
| Jun 30, 2025 | 65.08 Mn |
| Mar 31, 2025 | 54.62 Mn |
| Dec 31, 2024 | 68.46 Mn |
| Sep 30, 2024 | 62.24 Mn |
| Jun 30, 2024 | 54.68 Mn |
| Mar 31, 2024 | 46.96 Mn |
| Dec 31, 2023 | 47.41 Mn |
| Sep 30, 2023 | 43.89 Mn |
| Jun 30, 2023 | 34.08 Mn |
| Mar 31, 2023 | 35.05 Mn |
| Dec 31, 2022 | 38.86 Mn |
| Sep 30, 2022 | 30.76 Mn |
| Jun 30, 2022 | 26.98 Mn |
| Mar 31, 2022 | 15.46 Mn |
| Dec 31, 2021 | 14.79 Mn |
| Sep 30, 2021 | 14.34 Mn |
API Access
Viridian Therapeutics, Inc.\DE Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();